251 related articles for article (PubMed ID: 9847926)
1. Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984-1995.
Brown SL; Parmentier CM; Woo EK; Vishnuvajjala RL; Headrick ML
Public Health Rep; 1998; 113(6):535-43. PubMed ID: 9847926
[TBL] [Abstract][Full Text] [Related]
2. Infections related to breast implants reported to the Food and Drug Administration, 1977-1997.
Brown SL; Hefflin B; Woo EK; Parmentier CM
J Long Term Eff Med Implants; 2001; 11(1-2):1-12. PubMed ID: 11495100
[TBL] [Abstract][Full Text] [Related]
3. Surgical stapler-associated fatalities and adverse events reported to the Food and Drug Administration.
Brown SL; Woo EK
J Am Coll Surg; 2004 Sep; 199(3):374-81. PubMed ID: 15325606
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
5. US Food and Drug Administration: adverse event reporting.
Graham AA
CRNA; 1998 Nov; 9(4):135-8. PubMed ID: 9866488
[TBL] [Abstract][Full Text] [Related]
6. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women.
Brown SL; Pennello G; Berg WA; Soo MS; Middleton MS
J Rheumatol; 2001 May; 28(5):996-1003. PubMed ID: 11361228
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
8. Implications of transaxillary breast augmentation: lifetime probability of breast cancer development and sentinel node mapping interference.
Prado A; Andrades P; Leniz P
Aesthetic Plast Surg; 2007; 31(4):317-9. PubMed ID: 17549559
[TBL] [Abstract][Full Text] [Related]
9. Allergan's silicone gel breast implants.
Spear SL; Hedén P
Expert Rev Med Devices; 2007 Sep; 4(5):699-708. PubMed ID: 17850205
[TBL] [Abstract][Full Text] [Related]
10. Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature.
Levy Y; Rotman-Pikielny P; Ehrenfeld M; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1226-32. PubMed ID: 19880573
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
[TBL] [Abstract][Full Text] [Related]
12. The regulatory process, the Food and Drug Administration, and the silicone breast implant controversy.
Palley HA; Palley ML
J Health Soc Policy; 1999; 11(1):1-20. PubMed ID: 10538427
[No Abstract] [Full Text] [Related]
13. Breast implant adverse events during mammography: reports to the Food and Drug Administration.
Brown SL; Todd JF; Luu HM
J Womens Health (Larchmt); 2004 May; 13(4):371-8; discussion 379-80. PubMed ID: 15195650
[TBL] [Abstract][Full Text] [Related]
14. Silicone breast implants: an oncologic perspective.
Gerszten K; Gerszten PC
Oncology (Williston Park); 1998 Oct; 12(10):1427-33; discussion 1434, 1439-43. PubMed ID: 9798198
[TBL] [Abstract][Full Text] [Related]
15. Silicone gel breast implant failure: evaluation of properties of shells and gels for explanted prostheses and meta-analysis of literature rupture data.
Marotta JS; Goldberg EP; Habal MB; Amery DP; Martin PJ; Urbaniak DJ; Widenhouse CW
Ann Plast Surg; 2002 Sep; 49(3):227-42; discussion 242-7. PubMed ID: 12351970
[TBL] [Abstract][Full Text] [Related]
16. History of breast implants and the food and drug administration.
Spear SL; Parikh PM; Goldstein JA
Clin Plast Surg; 2009 Jan; 36(1):15-21, v. PubMed ID: 19055957
[TBL] [Abstract][Full Text] [Related]
17. Rupture of silicone gel breast implants and symptoms of pain and fatigue.
Vermeulen RC; Scholte HR
J Rheumatol; 2003 Oct; 30(10):2263-7. PubMed ID: 14528527
[TBL] [Abstract][Full Text] [Related]
18. [Silicone in autoimmune diseases and cancer].
Elejabeitia J
Rev Med Univ Navarra; 1999; 43(2):62-7. PubMed ID: 11256005
[TBL] [Abstract][Full Text] [Related]
19. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
Johann-Liang R; Wyeth J; Chen M; Cope JU
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
[TBL] [Abstract][Full Text] [Related]
20. Safely re-integrating silicone breast implants into the plastic surgery practice.
Gladfelter J
Plast Surg Nurs; 2006; 26(3):128-31. PubMed ID: 16990751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
